Advancing Material Innovation and Customer Care in the Medical Industry

• 

Frankfurt, Germany (PRWEB UK) 8 October 2013

At the K 2013, healthcare manufacturers facing increased regulation and escalating costs can get an inside look at how Styrolution, the global styrenics leader, is offering new solutions to ease their product development: cost-effective material advancements supported by reliable formulations and unparalleled service packages.

The healthcare applications of styrenics are growing as manufacturers look for more effective and safer delivery systems, state-of-the-art solutions to new challenges, and reliable formulations to reduce costly approval procedures. Styrenics are attractive to healthcare and diagnostic providers due to their cleanliness and safety, lower density, balanced performance, superior processing, excellent aesthetics and unsurpassed value for money.

As the global leader in styrenics with a legacy of more than 15 years serving healthcare and diagnostics, Styrolution will feature styrenics-based materials for sterilizable healthcare applications and HD service packages that go well beyond industry benchmarks. Also presented will be an array of customized solutions that are giving manufacturers a competitive edge and patients more range of choice.

Key points:

•     Styrenics are among the most important thermoplastics, with a broad range of applications for the healthcare and diagnostics market. In an industry with strict regulation and a focus on the long term, the potential for styrenics exists in the introduction of new polymers and potential substitutions for traditionaly used PC, TPE and PVC, in key applications.
•     Styrenics have a proven record of good to excellent chemical resistance to saturated hydrocarbons, ethanol, solutions containing alcohol, fats and oils, water, aqueous solutions of salts, detergents, mineral acids, glycerine, dilute acids and alkalis, and aliphatic amines and amides.
•     Styrolution is revitalizing customer care in the healthcare industry with best-in-class service packages, a broader medical-grade portfolio and product co-creation for customized solutions.
•     Styrolution’s full HD service package helps save time and money, so customers can focus their energies on product vision and design. Styrolution’s team of passionate professionals helps with everything from technical innovation and high-quality product development, to meeting strict worldwide regulatory requirements.
•     The Boehringer Ingelheim HandiHaler® uses two Styrolution grades: Novodur® HD is used in the mouthpiece and housing due to its mechanical properties and surface appearance. Terlux® HD, which is durable enough to withstand the forces applied during the piercing process within the device, is used in the transparent capsule chamber for easy patient monitoring.
•     Co-creation for innovative infusion bags and medical tubing: visitors to the K can experience first-hand the results of Styrolution’s collaboration with a leading medical supply producer to develop an innovative multi-layer film technology for infusion and collection bags, medical tubes and multi-layer tubes. Using Styroflex® (SBC), a cost-attractive, plasticizer-free alternative to current materials, film thickness is reduced by up to 50 percent while maintaining extremely high tear and perforation resistance and incredible transparency. For medical tubing, it also offers outstanding bonding performance and lower drug absorption compared with other plastics. Styrolution is fully committed to the healthcare industry, investing in its staff and resources with the ambition to be among the top three leading resin suppliers in healthcare and diagnostics.
•     Held from October 16-23, 2013 in Duesseldorf, Germany, the K is the number one trade fair for plastics and rubber worldwide and an international marketplace for visionary themes and innovative, sustainable solutions.

Visit http://www.k-tradefair.com/ for more information.

Product innovations featured at the K 2013:

•     Adhering to the highest medical standards, Zylar® 960 is enhanced for medical devices, infusion chambers and reusable drink ware used in the healthcare and diagnostics industry. Zylar 960 is an impact-modified styrene acrylic copolymer that provides toughness, transparency and superior processing characteristics for demanding injection-molding applications.
•     Providing parts with an excellent balance of transparency and toughness, Styrolux® 3G 46 is used as a performance modifier for polystyrene, making it more impact resistant while maintaining transparency. Used in infusion chambers and food container packaging, it features excellent thermoformability, heat resistance and very low permeability to aromas and gases.

Quotes:

Alexander Silvestre, Global Director of Healthcare & Diagnostics, Styrolution:
“We bring care into healthcare product innovation by offering full-service product packages that include everything from product co-creation to global industry compliance. We help our customers every step of the way to get innovations to the market faster.”

Roberto Gualdoni, CEO, Styrolution:
“In our ambition to lead healthcare and diagnostics as the most reliable partner in the industry, we invest strategically in research and development to help deliver solutions for age-related disease, point-of-care diagnostics and lighter, more portable devices.”

ABOUT STYROLUTION
Styrolution is the leading, global styrenics supplier with a focus on styrene monomer, polystyrene, standard ABS and styrenic specialties. With world-class production facilities and more than 80 years of experience, Styrolution helps its customers succeed by offering the best possible solution, designed to give them a competitive edge in their markets. The company provides styrenic applications for many everyday products across a broad range of industries, including automotive, electrical/electronics, building and construction, household appliances, toys, sports and leisure, packaging, and healthcare and diagnostics. In 2011, pro forma sales were at 6.6 billion euros, resulting in an EBITDA before special items of 317 million euros. Styrolution employs approximately 3,200 people and operates 17 production sites in ten countries.

For further information please visit http://www.styrolution.com.

The data and information contained in this document are presented in good faith and believed to be reliable, but shall not be part of the terms and conditions of sale of any Styrolution products. As many factors can affect product application and performance, each Styrolution customer must determine for itself, by conducting appropriate tests or other methods, whether a Styrolution product is suitable for their needs. STYROLUTION MAKES NO WRITTEN, ORAL, EXPRESS OR IMPLIED WARRANTY REGARDING THE PRODUCTS DESCRIBED HEREIN, THE RESULTS TO BE OBTAINED FROM THEIR USE, OR THE ACCURACY OR USE OF THE INFORMATION AND RECOMMENDATIONS CONTAINED HEREIN. STYROLUTION SPECIFICALLY DISCLAIMS THE WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. None of Styrolution’s products may be used in implants. Any purchase of Styrolution’s products for use in medical devices or pharmaceutical packaging is subject to our Global Healthcare & Diagnostics Policy.

CONTACT
Jeremy Whittaker
Global Manager, Public Relations

Styrolution Group GmbH
Erlenstrasse 2
60325 Frankfurt
Germany

Phone:    +49 069 509550-1025
Email:    jeremy.whittaker(at)styrolution(dot)com

PDF Print